YC
Yuval Cabilly
Managing Partner at Israel Biotech Fund
View Yuval's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Managing Partner
Dec 2014 - Present · 10 years
Board Member
Oct 2020 - Present · 4 years and 2 months
Board Member
May 2021 - Present · 3 years and 7 months
Company Details
2-10 Employees
Israel Biotech Fund – Building the future of Israeli Biotech Israel Biotech Fund seeks high value returns by identifying and maximizing the success of therapeutic assets of Israel-based biotech companies. Based in Rehovot, Israel’s main Biotech hub, we invest exclusively in Biotech companies developing drugs at or near clinical stages. Our partners include two top-tier international pharmaceuticals companies, institutional investors, family offices and high net worth individuals. Our key asset is a unique team of 25 Venture Advisors, comprised of renowned industry leaders and professionals who, together with the fund’s managing partners, provide our portfolio companies with hands-on guidance and support. We don’t just invest in promising companies – we have the ability, experience and network required to identify the best opportunities and partner with our portfolio companies to help them go the distance. We provide our portfolio companies with the necessary resources for long-term sustainable growth. This approach enhances their value and the investor’s long-term capital appreciation, while strengthening Israel’s Biotech industry which increases investment opportunities. The biotechnology industry in Israel is growing with enormous potential and we are determined to realize its full potential and real value. Team General Partners: David Sidransky, M.D., co-founder and general partner of Israel Biotech Fund. Yuval Cabilly, Ph.D., co-founder and general partner of Israel Biotech Fund. Ido Zairi, co-founder and general partner of Israel Biotech Fund. Venture Advisors Our key members include: Sol Barer, Ph.D., former Chairman and CEO of Celgene, currently serves on the board of several Biotech companies, including TEVA. Jeff Kindler, former Chairman & CEO of Pfizer. Robert Spiegel, MD, former Chief Medical Officer of Schering-Plough. Murray A. Goldberg, former CFO of Regeneron.
Year Founded
--
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
--
Keywords
BiotechnologyVenture Capitaland Israel
Discover More About Cleveland Clinic

Find verified contacts of Yuval Cabilly in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.